🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Zanamivir is a potent and highly selective inhibitor of the influenza virus...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-04-28
Trial ID
NCT02377401
Treatments Being Tested
The purpose of this study is to determine whether zanamivir aqueous solutio...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11
Trial ID
NCT01014988
Treatments Being Tested
This study is a 4 period study to see if there is any interaction between O...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00540501
Treatments Being Tested
Influenza infection is an important public health priority, with seasonal o...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-11-21
Trial ID
NCT04494412
Treatments Being Tested
The purpose of this study is to test the safety and efficacy of zanamivir g...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-01-15
Trial ID
NCT01231620
Treatments Being Tested
Approximately 40 healthy subjects will be enrolled. Each subject will parti...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05-19
Trial ID
NCT01353729
This study will be an open-label, multi-center, single arm study to evaluat...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-01-01
Trial ID
NCT01527110
Treatments Being Tested